Trial Profile
Efficacy of pixantrone and doxorubicin in paediatric patients with cancer.
Status:
Not stated
Phase of Trial:
Phase I
Latest Information Update: 22 Nov 2010
Price :
$35
*
At a glance
- Drugs Doxorubicin (Primary) ; Pixantrone (Primary)
- Indications Cancer; Lymphoid leukaemia; Solid tumours
- Focus Adverse reactions; Therapeutic Use
- Sponsors Cell Therapeutics
- 17 Nov 2010 New trial record